Provigil Related Published Studies
Well-designed clinical trials related to Provigil (Modafinil)
A placebo-controlled trial of modafinil for nicotine dependence. [2008.06.07]
Smoked cocaine self-administration is decreased by modafinil. [2008.03]
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. [2008.01.01]
A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. [2008.01]
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. [2007.12]
Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers. [2007.11]
Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial. [2007.08.08]
Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. [2007.05.15]
A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia. [2007.05]
Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. [2007.01.15]
Does modafinil enhance activity of patients with myotonic dystrophy?: a double-blind placebo-controlled crossover study. [2007.01]
Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study. [2006.12]
Impact of modafinil on prefrontal executive function in schizophrenia. [2006.12]
Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. [2006.11]
Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. [2006.08]
Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. [2006.07]
Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. [2006.05]
A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. [2006.05]
Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work. [2006.05]
A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. [2006.05]
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. [2006.04]
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. [2006.02]
Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study. [2006.02]
Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients. [2006.01]
Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. [2005.12]
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. [2005.12]
Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. [2005.11]
Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. [2005.09]
Modafinil for excessive sleepiness associated with shift-work sleep disorder. [2005.08.04]
Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. [2005.07]
Modafinil modulates anterior cingulate function in chronic schizophrenia. [2005.07]
Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. [2005.06]
Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. [2005.04.01]
Modafinil elicits sympathomedullary activation. [2005.04]
Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? [2005.04]
EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. [2005.02]
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. [2005.01]
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. [2005.01]
Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). [2005]
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. [2005]
EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. [2004.11]
The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia. [2004.10]
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. [2004.07]
The effects of modafinil and cognitive behavior therapy on sleep continuity in patients with primary insomnia. [2004.06.15]
Motor excitability and motor behaviour after modafinil ingestion--a double-blind placebo-controlled cross-over trial. [2004.06]
Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. [2004.05.15]
Modafinil improves alertness, vigilance, and executive function during simulated night shifts. [2004.05.01]
Modafinil improves recovery after general anesthesia. [2004.04]
Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. [2004.04]
Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness. [2004.03]
The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. [2004.03]
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. [2003.09]
Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. [2003.09]
Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. [2003.09]
Modafinil in children with attention-deficit hyperactivity disorder. [2003.08]
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. [2003.06]
Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies. [2003.06]
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. [2003.05.01]
Modafinil affects mood, but not cognitive function, in healthy young volunteers. [2003.04]
Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. [2003.03]
Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG. [2003.03]
Cognitive enhancing effects of modafinil in healthy volunteers. [2003.01]
Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. [2002.12.24]
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. [2002.12]
Effect of modafinil on core temperature during sustained wakefulness and exercise in a warm environment. [2002.11]
Circadian rhythm of rectal temperature during sleep deprivation with modafinil. [2002.10]
Steady-state pharmacokinetics and tolerability of modafinil administered alone or in combination with dextroamphetamine in healthy volunteers. [2002.04]
Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers. [2002.02]
Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. [2002.01]
Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. [2002.01]
Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. [2001.11.01]
Steady-state pharmacokinetics and tolerability of modafinil given alone or in combination with methylphenidate in healthy volunteers. [2001.08]
Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. [2001.03]
A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. [2000.06]
An evaluation of the abuse potential of modafinil using methylphenidate as a reference. [2000.03]
Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. [2000.01]
Health-related quality of life effects of modafinil for treatment of narcolepsy. [1999.09.15]
Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy. [1999.06]
Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? [1999.03]
A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. [1999.01]
Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. [1998.10]
Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. [1998.06]
Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers. [1998.03]
Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. [1997.08]
Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. [1997.06]
Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. [1997]
Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. [1995]
Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. [1993]
Well-designed clinical trials possibly related to Provigil (Modafinil)
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. [2008.04]
Drug management of terminal symptoms in advanced cancer patients. [2007.10]
Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia. [2006.08]
Sodium oxybate improves excessive daytime sleepiness in narcolepsy. [2006.07.01]
Practice parameters for the treatment of narcolepsy: an update for 2000. [2001.06.15]
Treatment modalities for narcolepsy. [1998.02]
Other research related to Provigil (Modafinil)
Impact of modafinil on spasticity reduction and quality of life in children with CP. [2008.07]
The effects of modafinil on mood and cognition in Huntington's disease. [2008.07]
The effects of modafinil on mood and cognition in Huntington's disease. [2008.06.01]
Therapeutic effects of Delta9-THC and modafinil in a marmoset Parkinson model. [2008.05]
Armodafinil: a new treatment for excessive sleepiness. [2008.04]
The effects of modafinil, caffeine, and dextroamphetamine on judgments of simple versus complex emotional expressions following sleep deprivation. [2008.04]
Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual. [2008.03.06]
|
